Cloning of equine interleukin 1 receptor antagonist and determination of its full-length cDNA sequence.

The study provided new information about the structure of a specific equine (horse) gene, the interleukin 1 receptor antagonist (IL-1ra). It worked to clone this gene and determine its full-length cDNA sequence, allowing for better understanding and further study of its function.

Methodology

The researchers used several key methods to accomplish their goal:

• The source of the gene for the study was a cDNA library derived from lipopolysaccharide-stimulated equine monocytes, a type of white blood cell in horses.
• They identified the equine IL-1ra gene by screening the library using plaque hybridization, a technique where radiolabeled DNA probes of the IL-1ra gene, made using the polymerase chain reaction (PCR), were used to detect matching sequences.
• The complete nucleotide sequence, a sequence of the four bases that make up DNA, of equine IL-1ra was determined with a method known as dideoxy chain termination, a popular method for sequencing DNA.

Results

The results revealed key characteristics of the equine IL-1ra gene:

• The cDNA for equine IL-1ra was 1,614 base pairs long.
• The open reading frame (ORF), the section of the gene that can be translated into a protein, encoded a peptide made of 177 amino acids.
• The predicted molecular mass of this peptide was 20.427 kilodaltons.
• The sequence showed 76% similarity with IL-1ra sequences from humans, mice, rats, and rabbits.
• The sequence was less similar to other interleukins (interleukin-1 alpha and beta) in horses, only displaying around 23% sequence identity.

Conclusion

The high level of similarity between the equine IL-ra sequence and those of other species indicates a high degree of conservation, meaning the gene hasn’t changed much through evolution. This study establishes a solid foundation for further research into the roles of interleukin-1 in healthy and diseased horse joints. Such research could eventually lead to targeted treatments or interventions for joint diseases in horses.